171 related articles for article (PubMed ID: 32575115)
1. Monoclonal immunoglobulins promote bone loss in multiple myeloma.
Westhrin M; Kovcic V; Zhang Z; Moen SH; Nedal TMV; Bondt A; Holst S; Misund K; Buene G; Sundan A; Waage A; Slørdahl TS; Wuhrer M; Standal T
Blood; 2020 Dec; 136(23):2656-2666. PubMed ID: 32575115
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss.
Harre U; Lang SC; Pfeifle R; Rombouts Y; Frühbeißer S; Amara K; Bang H; Lux A; Koeleman CA; Baum W; Dietel K; Gröhn F; Malmström V; Klareskog L; Krönke G; Kocijan R; Nimmerjahn F; Toes RE; Herrmann M; Scherer HU; Schett G
Nat Commun; 2015 Mar; 6():6651. PubMed ID: 25825024
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.
Yang J; Liu Z; Liu H; He J; Yang J; Lin P; Wang Q; Du J; Ma W; Yin Z; Davis E; Orlowski RZ; Hou J; Yi Q
Sci Signal; 2017 Dec; 10(509):. PubMed ID: 29233917
[TBL] [Abstract][Full Text] [Related]
4. Aberrant glycosylation of Igg heavy chain in multiple myeloma.
Aurer I; Lauc G; Dumić J; Rendić D; Matisić D; Milos M; Heffer-Lauc M; Flogel M; Labar B
Coll Antropol; 2007 Mar; 31(1):247-51. PubMed ID: 17598409
[TBL] [Abstract][Full Text] [Related]
5. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
Coleman EJ; Brooks KJ; Smallshaw JE; Vitetta ES
J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805
[TBL] [Abstract][Full Text] [Related]
6. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
Papadea C; Reimer CB; Check IJ
Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.
Ilić V; Milosević-Jovcić N; Petrović S; Marković D; Stefanović G; Ristić T
Glycoconj J; 2008 May; 25(4):383-92. PubMed ID: 18188696
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.
Bosseboeuf A; Seillier C; Mennesson N; Allain-Maillet S; Fourny M; Tallet A; Piver E; Lehours P; Mégraud F; Berthelot L; Harb J; Bigot-Corbel E; Hermouet S
Front Immunol; 2020; 11():854. PubMed ID: 32536913
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vivo model of human multiple myeloma bone disease.
Alsina M; Boyce B; Devlin RD; Anderson JL; Craig F; Mundy GR; Roodman GD
Blood; 1996 Feb; 87(4):1495-501. PubMed ID: 8608240
[TBL] [Abstract][Full Text] [Related]
10. Nonsecretory multiple myeloma with osteoporosis: immunocytologic and bone resorptive studies.
Van Slyck EJ; Kleerekoper M; Abraham JP; Deegan MJ
Am J Med Sci; 1986 May; 291(5):347-51. PubMed ID: 3518452
[TBL] [Abstract][Full Text] [Related]
11. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
12. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.
Mittermayr S; Lê GN; Clarke C; Millán Martín S; Larkin AM; O'Gorman P; Bones J
J Proteome Res; 2017 Feb; 16(2):748-762. PubMed ID: 27936757
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma with monoclonal surface immunoglobulin expression: a case report.
Dunphy CH; Galindo LM; Velasquez WS
Acta Cytol; 1996; 40(2):358-62. PubMed ID: 8629427
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
Kaneko Y; Nimmerjahn F; Ravetch JV
Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
[TBL] [Abstract][Full Text] [Related]
16. In vitro production of monoclonal and polyclonal immunoglobulins by peripheral blood mononuclear cells in human plasma cell myeloma.
Peest D; Holm G; Mellstedt H; Pettersson D
Scand J Immunol; 1982 Jun; 15(6):595-603. PubMed ID: 7123157
[TBL] [Abstract][Full Text] [Related]
17. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
[TBL] [Abstract][Full Text] [Related]
19. Serum protein N-glycosylation changes in multiple myeloma.
Zhang Z; Westhrin M; Bondt A; Wuhrer M; Standal T; Holst S
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):960-970. PubMed ID: 30844485
[TBL] [Abstract][Full Text] [Related]
20. An unusual case of Bence Jones myeloma with extremely low levels of monoclonal immunoglobulin.
Ozaki M; Yamanaka H
Oral Surg Oral Med Oral Pathol; 1986 May; 61(5):498-503. PubMed ID: 3086787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
